Announcing NYS Approval for Three Additional Region of Interest Tests and Mitochondrial DNA Analysis

NYS Approval for Bone Marrow Failure, HLH, Nephrotic Syndrome, and Mitochondrial DNA Analysis

June 22, 2017

Claritas Genomics is pleased to announce it has received approval from the New York State Department of Health for three Region of Interest tests and Mitochondrial DNA analysis for the Claritas Clinical Exome. For the full list of NYS approved offerings, please visit our For New York State Providers page. Read the full press release here.

About Claritas

Claritas Genomics serves children affected with complex genetic disorders by providing timely and accurate results, resolving families’ long search for answers. By combining clinical expertise of the world’s best pediatric specialists with innovative platform solutions, Claritas is working to improve patient care and enable new discoveries. We are committed to the highest quality and accessibility of information and our interpretive services and unique approach to reporting set the standard for reliably and clearly communicating genetic information.

Now is the time to integrate genomics into clinical practice to inform, guide and improve medical treatment for kids around the world.